HomeCompareEMITF vs PLD

EMITF vs PLD: Dividend Comparison 2026

EMITF yields 111.11% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $430.2K in total portfolio value· pulled ahead in Year 10
10 years
EMITF
EMITF
● Live price
111.11%
Share price
$1.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.07M
Annual income
$2,192,447.17
Full EMITF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — EMITF vs PLD

📍 PLD pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMITFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMITF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMITF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMITF
Annual income on $10K today (after 15% tax)
$9,444.44/yr
After 10yr DRIP, annual income (after tax)
$1,863,580.09/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $2,604,390.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMITF + PLD for your $10,000?

EMITF: 50%PLD: 50%
100% PLD50/50100% EMITF
Portfolio after 10yr
$6.29M
Annual income
$3,724,441.67/yr
Blended yield
59.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

EMITF
No analyst data
Altman Z
-0.0
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMITF buys
0
PLD buys
0
No recent congressional trades found for EMITF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMITFPLD
Forward yield111.11%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$6.07M$6.50M
Annual income after 10y$2,192,447.17$5,256,436.18
Total dividends collected$5.48M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: EMITF vs PLD ($10,000, DRIP)

YearEMITF PortfolioEMITF Income/yrPLD PortfolioPLD Income/yrGap
1$21,811$11,111.11$11,255$555.24+$10.6KEMITF
2$45,987$22,649.13$13,062$1,018.59+$32.9KEMITF
3$93,836$44,629.82$15,903$1,926.67+$77.9KEMITF
4$185,513$85,108.97$20,839$3,823.32+$164.7KEMITF
5$355,752$157,252.56$30,464$8,166.08+$325.3KEMITF
6$662,484$281,829.11$52,054$19,457.30+$610.4KEMITF
7$1,199,347$490,489.82$109,886$54,188.93+$1.09MEMITF
8$2,113,183$829,881.38$304,030$186,451.18+$1.81MEMITF
9$3,627,652$1,366,546.40$1,166,125$840,813.32+$2.46MEMITF
10← crossover$6,074,035$2,192,447.17$6,504,190$5,256,436.18$430.2KPLD

EMITF vs PLD: Complete Analysis 2026

EMITFStock

Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.

Full EMITF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this EMITF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMITF vs SCHDEMITF vs JEPIEMITF vs OEMITF vs KOEMITF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.